A green light from the CDC will pave the way for 3.2 million doses of the Novavax vaccine to be distributed in the U.S.
A Centers for Disease Control and Prevention advisory panel voted Tuesday to recommend Novavax’s two-dose COVID-19 vaccine for adults.last week, but the CDC must sign off before doses can be distributed to the public. Now that the agency’s advisory panel has weighed in affirmatively, it is up to CDC Director Dr. Rochelle Walensky to endorse the recommendation. In the past, that step has followed within the same day as the committee’s vote.
The shot could fill a gap in the U.S. vaccination push, since it does not use mRNA technology. Around 22% of people in the U.S. still have not received a single COVID-19 vaccine,“The primary target population for Novavax will be ... those that are unvaccinated,” Dr. Oliver Brooks, an advisory committee member and the chief medical officer at Watts Healthcare Corp., said after the panel vote.
Both Pfizer-BioNTech’s and Moderna’s vaccines, by contrast, were the first mRNA vaccines authorized. They use a snippet of the coronavirus’s genome to instruct the body to produce the spike protein internally, which triggers the development of antibodies.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Experts Warn of Latest COVID-19 Subvariant as CDC Raises Dallas County Threat Level to RedDallas County is seeing a spike in COVID-19 cases thanks to the highly transmissible BA.5 subvariant.
Weiterlesen »
CDC ends COVID-19 monitoring program for cruise shipsCruise ships were among the first impacted by COVID-19 in 2020. The CDC issued no-sail orders, which kept ships at bay for months into the pandemic.
Weiterlesen »
The CDC has ended its COVID-19 program for cruise shipsThe Centers for Disease Control and Prevention says that as of Monday, its COVID-19 program for cruise ships is no longer in effect, and the agency will no longer share each ship’s COVID status with the public.
Weiterlesen »
Novavax’s Covid-19 Vaccine Wins CDC Advisers’ BackingVaccine experts advising the CDC backed use of Novavax’s Covid-19 vaccine in adults 18 years and older, one of the last steps before the shots become widely available
Weiterlesen »
CDC advisory panel votes to recommend the Novavax Covid vaccineA green light from the CDC will pave the way for 3.2 million doses of the Novavax vaccine to be distributed in the United States.
Weiterlesen »
CDC panel endorses new Novavax COVID vaccineAdvisors to the Centers for Disease Control and Prevention voted Tuesday to endorse emergency authorization of a new COVID-19 vaccine developed by the Maryland biotechnology company Novavax, making it the fourth immunization to clear that hurdle in the U.S. — and the first to rely on the same familiar technology as some seasonal flu shots.
Weiterlesen »